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Abstract
Introduction: Syphilis is a chronic infection caused by Trepo-
nema pallidum. Manifestations of this disease are vast, and 
syphilitic hepatitis is a rarely depicted form of secondary 
syphilis. Case Presentation: We report the case of a 63-year-
old man with worsening jaundice, maculopapular rash and 
perianal discomfort. Proctological examination with anos-
copy revealed a perianal gray/white area with millimetric 
pale granules along the anal canal. Liver function tests 
showed a mixed pattern. Venereal Disease Research Labora-
tory, T. pallidum hemagglutination assay and IgM fluores-
cent treponemal antibody absorbance were positive. The 
patient was successfully treated with a single dose of penicil-
lin G. Discussion/Conclusion: Syphilitic hepatitis is scarcely 
reported in the literature. Secondary syphilis with mild hep-
atitis rarely leads to hepatic cytolysis and jaundice. Many 
signs of secondary syphilis including syphilitic hepatitis may 
be linked to immune responses initiated during early infec-
tion. Over the past decades, evidence has emerged on the 
importance of innate and adaptive cellular immune respons-
es in the immunopathogenesis of syphilis. This report raises 
awareness to a clinical entity that should be considered in 
patients at risk for sexually transmitted diseases, who pres-
ent with intestinal discomfort or liver dysfunction, as it is a 
treatable and fully reversible condition.
© 2021 Sociedade Portuguesa de Gastrenterologia
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Explorando as manifestações do “Grande Imitador”: 
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Resumo
Introdução: A sífilis é uma infeção crónica provocada pelo 
Treponema pallidum. As manifestações desta doença são 
vastas e a hepatite sifilítica é uma forma de sífilis secundária 
raramente descrita. Caso Clínico: Apresentamos o caso 
de um doente de 63 anos com icterícia de agravamento 
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progressivo, rash maculopapular e desconforto perianal. 
O exame proctológico complementado por anuscopia 
revelou uma região perianal cinzenta-esbranquiçada com 
grânulos pálidos milimétricos ao longo do canal anal. Tes-
tes de função hepática revelaram um padrão misto e o 
Venereal Disease Research Laboratory, T. pallidum hem-
agglutination assay e IgM fluorescent treponemal anti-
body absorbance foram positivos. O doente foi tratado 
com sucesso com uma dose única de penicilina G. Dis-
cussão/Conclusão: São raros os casos de hepatite sifilítica 
descritos na literatura. Sífilis secundária com hepatite 
ligeira raramente conduz a citólise hepática e icterícia. 
Muitos dos sinais de sífilis secundária, incluindo a hepatite 
sifilítica, parecem estar associados a respostas imunitárias 
iniciadas durante o período de infeção precoce. Ao longo 
das últimas décadas, têm surgido evidências crescentes 
sobre a importância das respostas imunes inata e adapta-
tiva na patogénese da sífilis. Este caso clínico descreve 
uma entidade nosológica que deve ser considerada em 
doentes em risco de contraírem doenças sexualmente 
transmissíveis, que se apresentem com desconforto intes-
tinal ou disfunção hepática, visto tratar-se de uma 
condição tratável e totalmente reversível.
© 2021 Sociedade Portuguesa de Gastrenterologia
Publicado por S. Karger AG, Basel
Introduction
Syphilis is a chronic infection caused by Treponema 
pallidum. Nowadays, we have a relatively complete un-
derstanding of the natural history of untreated syphilis. 
However, the pathogenic mechanism of T. pallidum is 
still not fully understood [1]. Some authors suggest that 
manifestations like syphilitic hepatitis (SH) are likely due 
to innate and adaptative cellular immune responses.
Case Report
A 63-year-old man was admitted to the Emergency Depart-
ment with a 1-month history of worsening jaundice and perianal 
discomfort. The patient had an unremarkable medical history. He 
denied any medication, alcohol consumption, drug administra-
tion or unprotected sexual intercourse.
Physical examination revealed icteric skin and mucosae and a 
maculopapular rash on the palms, inguinal region, legs and soles 
(Fig. 1). Genital lesions, such as chancre, were discarded. Procto-
logical examination revealed a perianal gray/white area and pain-
less nodular lesions on the superior anal canal and distal rectum. 
Anoscopy confirmed millimetric pale granules along the anal ca-
nal.
Liver function tests on admission showed a mixed pattern – to-
tal/direct bilirubin of 8.3/6.9 mg/dL (normal: 0.3–1 mg/dL), aspar-
tate aminotransferase of 105 IU/L (normal: <34 IU/L), alanine 
aminotransferase of 188 IU/L (normal: <44 IU/L) and alkaline 
phosphatase (ALP) of 670 IU/L (normal: <120 IU/L). Further in-
vestigations including hepatitis A, B and C, HIV, cytomegalovirus 
and Epstein-Barr serology, ceruloplasmin, α1-antitrypsin, iron 
studies, smooth muscle, antinuclear and antimitochondrial anti-
bodies were unremarkable.
Abdominal ultrasound revealed a normal liver parenchyma 
and biliary tree. Colonoscopy showed an indurated nodular mu-
cosa around the rectal lumen (Fig. 2–4). Histology of the biopsied 
rectal mucosa revealed an unspecific inflammatory cell infiltrate.
ALP levels increased to 1,355 IU/L, and the maculopapular le-
sions remained unresolved. Suspecting a dermatological disease 
with perianal manifestations, consultation by Dermatology was re-
quested, along with serological tests for syphilis. Results showed a 
Venereal Disease Research Laboratory (VDRL) titer of 1/256, a T. 
pallidum hemagglutination assay (TPHA) of 1/5,120 and a positive 
IgM fluorescent treponemal antibody absorbance (IgM FTA-abs). 
At this point, the patient mentioned one unprotected heterosexu-
al intercourse with a shared object, 2 months before the onset of 
symptoms.
The patient was treated with a single dose of penicillin G ben-
zathine (2.4 million units intramuscularly). Jaundice and the rash 
lesions progressively subsided. Cytolysis resolved and cholestasis 
gradually disappeared. IgM FTA-abs results became negative, 
whereas VDRL and TPHA titers decreased over time.
Response to the standard regimen for early syphilis allowed the 
authors to confirm the diagnosis of SH.
Discussion/Conclusion
Untreated syphilitic infections may cause the wide-
spread dissemination of T. pallidum, and approximately 
25% of patients will primarily exhibit a systemic illness, 
representing the secondary stage of syphilis [2].
Condylomata lata are relatively common, occurring in 
about one third of patients suffering from syphilis. How-
ever, proctitis and hepatitis are a much less studied reflec-
tion of secondary syphilis (SS).
Regarding the absence of genital wounds, we consid-
ered the proctological lesions as the primary site of in-
oculation. Despite these, biopsies of the rectal mucosa 
failed to show spirochetes. However, it is well established 
that T. pallidum is impossible to visualize by direct mi-
croscopy and unable to grow in culture [1].
The frequency of SH ranges from 1 to 50% [3], but it 
is rarely reported in the literature. Mild hepatitis charac-
terized by high serum ALP levels is the most frequent he-
patic manifestation of SS, but it rarely leads to hepatic 
cytolysis and jaundice [4, 5].
Some authors report that liver biopsies of patients with 
SH may reveal focal necrosis, acute inflammatory infil-
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trate, Kupffer cell hyperplasia and bile duct injury. In ad-
dition, spirochetes may be identified using silver staining. 
However, the majority of case reports failed to reveal 
treponemes in liver biopsies [6–9].
Since our patient had a classical skin involvement, 
highly suspicious of syphilis, we decided to ask for an ear-
ly dermatology consultation, prior to a liver biopsy.
According to the diagnostic criteria established by 
Mullick et al. [10], patients with abnormal liver enzyme 
levels, serological evidence for syphilis with a positive 
TPHA titer in conjunction with an acute clinical presen-
tation consistent with SS, exclusion of alternative causes 
of hepatic injury and improvements in liver enzyme levels 
with an appropriate antimicrobial therapy can securely be 
diagnosed with SH without the need of a liver biopsy. Re-
garding that, our patient met all the aforementioned cri-
teria, and to prevent unnecessary invasive procedures, we 
therefore decided not to perform a liver biopsy.
Although some authors still prefer the administration 
of 3 doses of penicillin G benzathine (2.4 million units 
intramuscularly) each at 1-week intervals [4, 8], evidence 
suggests a lower number of cures with a triple dose of 
penicillin G benzathine compared to a single dose of pen-
icillin G benzathine [11]. Current treatment guidelines 
advocate a single dose of penicillin G benzathine (2.4 mil-
lion units intramuscularly) as the recommended regimen 
for SS [11, 12].
Many signs of SS including SH may be linked to im-
mune responses initiated during early infection [13]. 
Over the past decades, evidence has emerged on the im-
portance of innate and adaptive cellular immune re-
sponses in the immunopathogenesis of syphilis [14]. The 
adaptive component was documented first, with the pub-
lication of experiments in rabbit models showing that the 
replication of treponemes at the inoculation site elicited 
an intense inflammatory response resembling a delayed-
Fig. 1. Maculopapular rash on the palms.
Fig. 2. Tubular rectum – hardened and erythematous mucosa with 
pale nodular lesions.
Fig. 3. Tubular rectum – hardened and erythematous mucosa with 
pale nodular lesions.
Fig. 4. Retroflexion in the rectum – hardened and erythematous 
mucosa with pale nodular lesions.
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type hypersensitivity reaction [13]. Immunohistochemi-
cal analysis revealed that syphilitic lesions in humans also 
contained cellular elements associated with adaptive im-
munity, including cytokine-producing Th1 cells. The 
contribution of innate responses to lesion development 
and resolution was studied both in vitro and in vivo, es-
tablishing that spirochetal lipoproteins are capable of ac-
tivating macrophages via CD14 and Toll-like receptor 1/2 
signaling pathways. Hence, these pathogen-associated 
molecular patterns are now believed to be the major pro-
inflammatory agonists during spirochetal infection [15, 
16]. Despite this apparent immune control, simultaneous 
widespread dissemination of spirochetes occurs.
Clinicians should bear in mind the possibility of syph-
ilitic involvement in patients at risk for sexually transmit-
ted diseases who present with intestinal discomfort or 
liver dysfunction, as it is a treatable and fully reversible 
condition.
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